Available online 7 October 2025
# Strong Correlation of PROMIS Upper Extremity and Shoulder Arthroplasty Smart Score to Legacy Measures in Shoulder Arthroplasty Patients
Author links open overlay panelKai Zhu BS 1,
Chimdi Obinero BS 1,
Wura Adegbite BS 1,
Anton Khlopas MD 1,
Mahdi Mazeh BS 1,
Jared Mahylis MD 1,
Stephanie Muh MD 1Show more## Abstract
### Background
Patient-Reported Outcome Measures (PROMs) are vital to evaluating surgical outcomes. Legacy PROMs, such as the American Shoulder and Elbow Surgeons (ASES) score, have been the standard for examining upper extremity (UE) function but are not without limitations. Newer tools such as the Patient-Reported Outcomes Measurement Information System (PROMIS) UE and Shoulder Arthroplasty Smart (SAS) score offer potential improved sensitivity in assessing UE outcomes. The goal of this study was to assess the accuracy of both PROMIS UE and SAS to the established legacy ASES score.
### Methods
A retrospective study of patients who underwent primary shoulder arthroplasty (SA) from 2020 to 2022 were analyzed for PROMs using ASES, PROMIS UE, and SAS. Pearson correlation coefficients were obtained to compare ASES to PROMIS UE as well as ASES to SAS scores from patients with a minimum of 2-year follow-up. Ceiling effect analysis was conducted using ASES, PROMIS UE, and SAS scores.
### Results
A total of 70 patients met inclusion criteria and were analyzed. The mean final follow-up was 2.48 years. The correlation of ASES vs. PROMIS UE was noted to be excellent-good, and excellent, at 6-month (r =0.647, p value <0.001) and at the minimum 2-year follow-up (r = 0.761, p value <0.001) respectively. When comparing ASES vs. SAS, the correlation was excellent-good, or excellent, with the 6-month, 1 year, and 2-year follow-up (r = 0.748, r = 0.738, and r = 0.688 respectively p value <0.001). Ceiling effect analysis showed low ceiling effects at the 2-year minimum follow-up, with the percentage of patients achieving the maximum ASES, PROMIS UE, and SAS scores being 0.23%, 0.91%, and 0.00% respectively.
### Conclusions
The present study suggests PROMIS UE and SAS are effective, shoulder-specific alternatives to legacy instruments. Both instruments showed strong, increasing correlations with ASES through 2 years follow-up and demonstrated low ceiling effects, indicating sensitivity across a broad functional range. These results highlight the clinical utility of PROMIS UE and SAS for patient-centered outcome assessment in SA populations.
## Keywords
Patient reported outcome measure
Primary shoulder arthroplasty
Shoulder arthroplasty
PROMIS upper extremity
ASES
Shoulder arthroplasty smart score
Recommended articles
Â© 2025 The Authors. Published by Elsevier Inc. on behalf of American Shoulder and Elbow Surgeons.